The rise of copyright’s blockbuster initially drove a period of growth for the drug industry, however recent developments present a murky picture for shareholders. Lower-cost competitors are eroding revenue, and https://karimnbhy882255.dgbloggers.com/41609029/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-play